↓ Skip to main content

Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis

Overview of attention for article published in Frontiers in Pharmacology, October 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

twitter
15 X users

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
20 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Evaluation of Pirfenidone and Nintedanib in a Human Lung Model of Fibrogenesis
Published in
Frontiers in Pharmacology, October 2021
DOI 10.3389/fphar.2021.679388
Pubmed ID
Authors

KM Roach, E Castells, K Dixon, S Mason, G Elliott, H Marshall, MA Poblocka, S Macip, M Richardson, L Khalfaoui, P Bradding

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 20 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 20 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 4 20%
Other 2 10%
Professor > Associate Professor 1 5%
Lecturer 1 5%
Student > Doctoral Student 1 5%
Other 5 25%
Unknown 6 30%
Readers by discipline Count As %
Unspecified 4 20%
Pharmacology, Toxicology and Pharmaceutical Science 3 15%
Medicine and Dentistry 3 15%
Biochemistry, Genetics and Molecular Biology 2 10%
Nursing and Health Professions 1 5%
Other 0 0%
Unknown 7 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 October 2021.
All research outputs
#2,941,267
of 23,310,485 outputs
Outputs from Frontiers in Pharmacology
#1,193
of 16,763 outputs
Outputs of similar age
#67,421
of 434,498 outputs
Outputs of similar age from Frontiers in Pharmacology
#43
of 1,092 outputs
Altmetric has tracked 23,310,485 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,763 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,498 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 1,092 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.